QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Résumé Extracto Full Text PDF Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Articles Ahead of Print [Order Reprint] Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Calhoun, D. A Articles by Bhatt-Mehta, V. Search for Related Content PubMed PubMed Citation Articles by Calhoun, D. A Articles by Bhatt-Mehta, V.

NEONATOLOGY

Recent Advances in Neonatal Pharmacotherapy

DO, Medical Director of the Neonatal Intensive Care Unit, Sarasota Memorial Hospital, All Children's Hospital/West Coast Neonatology, Sarasota, FL

S Narasimha Murthy

PhD, Assistant Professor, Pharmaceutical Sciences, Raabe College of Pharmacy, Ohio Northern University, Ada, OH

Bobby G Bryant

PharmD MS, Dean and Professor of Pharmacy, Raabe College of Pharmacy, Ohio Northern University

Sherry A Luedtke

PharmD, Associate Dean, Professional Affairs, Associate Professor, Pharmacy Practice, Texas Tech University HSC School of Pharmacy, Amarillo, TX 79106

Varsha Bhatt-Mehta

PharmD FCCP, Clinical Associate Professor, Pharmacy, Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI

Reprints: Dr. Bhatt-Mehta, Department of Pharmacy F2758, CS Mott Children's Hospital, 200 E. Hospital Dr., Ann Arbor, MI 48109-0221, fax 734/936-6946, varsham{at}umich.edu

Abstract

OBJECTIVE: To provide commentary and reviews and brief discussions in controversial or innovative recent advances in neonatal pharmacotherapy. To discuss cutting edge drug delivery systems that may become useful in neonatal drug delivery in the future.

DATA SOURCES: Articles were identified through searches of MEDLINE (1990-October 2005), key articles in the authors' files, and in some cases, through data generated and/or published by the author of a particular topic.

DATA SELECTION: Article selection and relevance to the topics under discussion was determined by individual authors.

DATA SYNTHESIS: Therapeutic strategies addressed in this review include the use of hematopoietic growth factors including a simulated amniotic fluid preparation containing these growth factors for neonates with selected gastrointestinal problems, erythropoietin for neuroprotection following perinatal asphyxia, drug therapy advances in treatment of patent ductus arteriosus (PDA), evaluation of advances in transdermal drug delivery, and its potential application to neonates and advances in the treatment of persistent pulmonary hypertension (PPHN) of the newborn.

CONCLUSIONS: Despite being over 30 years old, the practice of neonatology is as much of an art as a science. Advances in the basic science research have improved our understanding of use of pharmacologic agents in the premature and full-term neonate including drug disposition pathways. Expanding our knowledge on issues such as physiology of hematopoietic factors, the pharmacologic responses of conditions such as PDA and PPHN, and newer technologies for drug administration, as well as other pharmacologic reponses in the neonate are vital in the development of safe and efficacious treatments for neonates. Many questions remain unanswered, and every clinician must make an effort to contribute to the knowledge and understanding of pharmacotherapy in this patient population.

Key Words: neonates, patent ductus arteriosus, persistent pulmonary hypertension

Published Online, March 28, 2006. www.theannals.com, DOI 10.1345/aph.1G212

This article has been cited by other articles:

				R. J Holt Comment: Recent Advances in Neonatal Pharmacotherapy Ann. Pharmacother., September 1, 2006; 40(9): 1697 - 1697. [Full Text] [PDF]